Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

When cancer is detected earlier, it can improve outcomes for patients. Liquid biopsies are one way to improve cancer detection; these tests can analyze DNA in blood samples, which can reveal the ...

A new study has mapped the distinct molecular "fingerprints" that 59 diseases leave in an individual's blood protein, which could enable blood tests to discern troubling signs from those that are more ...